跳至主要内容
临床试验/IRCT20211227053546N1
IRCT20211227053546N1招募中2 期

Study of zinc supplement on oxidative stress and inflammation markers in multiple myeloma patients undergo autologous hematopoietic stem cell transplantation compared with placebo

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 60 years(—)
性别
All

入选标准

  • Complete response to treatment
  • Lack of underlying disease
  • Do not get any infection in the last three months, including COVID19
  • Age range 40 to 60 years
  • Patients with a history of multiple myeloma

排除标准

  • History of sensitivity to zinc oral supplement
  • Serum levels above 200 mg/dl
  • Patients who have taken oral supplements for three months before transplantation.
  • People's unwillingness to collaborate in the study

研究者

相似试验

Zinc supplement effect on oxidative stress and... | 临床试验